186 related articles for article (PubMed ID: 33527014)
1. Anti-EGFR treatment effects on laryngeal cancer stem cells.
Fernandes GMM; Galbiatti-Dias ALS; Ferreira LAM; Serafim Junior V; Rodrigues-Fleming GH; de Oliveira-Cucolo JG; Biselli-Chicote PM; Kawasaki-Oyama RS; Maniglia JV; Pavarino ÉC; Goloni-Bertollo EM
Am J Transl Res; 2021; 13(1):143-155. PubMed ID: 33527014
[TBL] [Abstract][Full Text] [Related]
2. Relationship between CD44
Silva Galbiatti-Dias AL; Fernandes GMM; Castanhole-Nunes MMU; Hidalgo LF; Nascimento Filho CHV; Kawasaki-Oyama RS; Ferreira LAM; Biselli-Chicote PM; Pavarino ÉC; Goloni-Bertollo EM
Am J Cancer Res; 2018; 8(8):1633-1641. PubMed ID: 30210931
[TBL] [Abstract][Full Text] [Related]
3. Treatment effects of the EGFR pathway drugs on head and neck cancer stem cells.
Fernandes GMM; Serafim Junior V; Galbiatti-Dias ALS; Ferreira LAM; Castanhole-Nunes MMU; Kawasaki-Oyama RS; Maniglia JV; Pavarino EC; Goloni-Bertollo EM
Am J Cancer Res; 2022; 12(9):4196-4210. PubMed ID: 36225637
[TBL] [Abstract][Full Text] [Related]
4. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
[TBL] [Abstract][Full Text] [Related]
5. Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44/CD117 in human ovarian cancer SKOV3 cells.
Fan Y; Cheng H; Liu Y; Liu S; Lowe S; Li Y; Bentley R; King B; Tuason JPW; Zhou Q; Sun C; Zhang H
Front Pharmacol; 2022; 13():955984. PubMed ID: 36046821
[No Abstract] [Full Text] [Related]
6. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
[TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of CD133
Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
[TBL] [Abstract][Full Text] [Related]
8. A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment.
La Fleur L; Johansson AC; Roberg K
PLoS One; 2012; 7(9):e44071. PubMed ID: 23049743
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
[TBL] [Abstract][Full Text] [Related]
10. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
[TBL] [Abstract][Full Text] [Related]
11. Clonogenically Culturing and Expanding CD34+ Liver Cancer Stem Cells in Vitro.
Park SC; Zeng C; Tschudy-Seney B; Nguyen NT; Eun JR; Zhang Y; Ramsamooj R; Zhang Y; Zhao M; Theise ND; Zhou H; Zern MA; Duan Y
Stem Cells Dev; 2015 Jul; 24(13):1506-14. PubMed ID: 25867583
[TBL] [Abstract][Full Text] [Related]
12. [Biological characteristics of highly tumorigenic CD44+CD133+ subpopulation of laryngeal carcinoma cells].
Yu D; Jin CS; Chen O; Wen LJ; Gao LF
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):99-103. PubMed ID: 19538883
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
14. Cancer Stem Cell Traits in Tumor Spheres Derived from Primary Laryngeal Carcinoma Cell Lines.
Kumbar VM; Muddapur UM; Bhat KG; Shwetha HR; Kugaji MS; Peram MR; Dindawar S
Contemp Clin Dent; 2021; 12(3):247-254. PubMed ID: 34759681
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of CD133
Wang J; Wu Y; Gao W; Li F; Bo Y; Zhu M; Fu R; Liu Q; Wen S; Wang B
J Cancer; 2017; 8(3):497-506. PubMed ID: 28261352
[No Abstract] [Full Text] [Related]
16. PKI-587 and sorafenib alone and in combination on inhibition of liver cancer stem cell proliferation.
Gedaly R; Galuppo R; Musgrave Y; Angulo P; Hundley J; Shah M; Daily MF; Chen C; Cohen DA; Spear BT; Evers BM
J Surg Res; 2013 Nov; 185(1):225-30. PubMed ID: 23769634
[TBL] [Abstract][Full Text] [Related]
17. Identification and Characterization of CD133(pos) Subpopulation Cells From a Human Laryngeal Cancer Cell Line.
Qiu HO; Wang H; Che N; Li D; Mao Y; Zeng Q; Ge R
Med Sci Monit; 2016 Apr; 22():1146-51. PubMed ID: 27049928
[TBL] [Abstract][Full Text] [Related]
18. Novel triple‑positive markers identified in human non‑small cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics.
Satar NA; Fakiruddin KS; Lim MN; Mok PL; Zakaria N; Fakharuzi NA; Abd Rahman AZ; Zakaria Z; Yahaya BH; Baharuddin P
Oncol Rep; 2018 Aug; 40(2):669-681. PubMed ID: 29845263
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a subpopulation of CD133
Gao J; Yang T; Wang X; Zhang Y; Wang J; Zhang B; Tang D; Liu Y; Gao T; Lin Q; Tang J; Cai J
Cancer Cell Int; 2021 Mar; 21(1):157. PubMed ID: 33685462
[TBL] [Abstract][Full Text] [Related]
20. Enhanced anticancer effect of oncostatin M combined with salinomycin in CD133
Fu C; Wang L; Tian G; Zhang C; Zhao Y; Xu H; Su M; Wang Y
Oncol Lett; 2019 Feb; 17(2):1798-1806. PubMed ID: 30675240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]